大洋生物(003017) - 2024 Q3 - 季度财报

Revenue and Profit Performance - Revenue for the third quarter was RMB 234.57 million, a slight increase of 0.64% year-over-year[3] - Net profit attributable to shareholders was RMB 19.83 million, up 21.51% compared to the same period last year[3] - Total revenue for the period was 671,793,437.23 RMB, a decrease from 714,741,924.74 RMB in the previous period[14] - Net profit for the period was 51,265,777.40 RMB, an increase from 40,176,231.69 RMB in the previous period[15] - Operating profit increased to 54,398,797.61 RMB from 39,880,452.30 RMB[15] - Total revenue from sales of goods and provision of services was RMB 626.56 million, compared to RMB 608.06 million in the previous period[17] Assets and Liabilities - Total assets increased by 4.25% to RMB 1.61 billion compared to the end of the previous year[3] - Total assets increased to 1,612,419,017.26 RMB from 1,546,672,439.50 RMB[12] - Total liabilities increased to 584,346,699.96 RMB from 538,465,015.51 RMB[12] - Total equity increased to 1,028,072,317.30 RMB from 1,008,207,423.99 RMB[13] - The company's monetary funds at the end of the period are 315,569,749.06 yuan, a decrease from 382,366,361.27 yuan at the beginning of the period[11] - The company's accounts receivable increased to 71,186,203.85 yuan from 38,434,825.43 yuan at the beginning of the period[11] - The company's inventory decreased to 131,329,384.49 yuan from 152,230,263.34 yuan at the beginning of the period[11] - The company's long-term equity investments increased to 85,812,883.33 yuan from 35,446,937.95 yuan at the beginning of the period[11] - The company's fixed assets increased to 524,150,839.71 yuan from 489,418,459.44 yuan at the beginning of the period[11] - The company's construction in progress decreased to 148,981,005.50 yuan from 180,840,561.29 yuan at the beginning of the period[11] - The company's total current assets at the end of the period are 667,068,405.96 yuan, slightly increased from 661,633,569.19 yuan at the beginning of the period[11] - Deferred tax assets decreased to 39,794,835.79 RMB from 44,169,382.62 RMB[12] - Other non-current assets increased to 34,798,674.02 RMB from 20,842,727.56 RMB[12] Cash Flow and Financing - Investment activities resulted in a net cash outflow of RMB 155.85 million, a 173.40% decrease compared to the same period last year[7] - The company's short-term borrowings increased by 87.64% to RMB 338.57 million due to increased bank financing[6] - Short-term borrowings increased to 338,568,451.48 RMB from 180,434,535.37 RMB[12] - Net cash flow from operating activities was RMB 53.55 million, a decrease from RMB 70.71 million in the previous period[17] - Net cash flow from investing activities was negative RMB 155.85 million, compared to positive RMB 212.32 million in the previous period[18] - Net cash flow from financing activities was RMB 29.28 million, down from RMB 52.41 million in the previous period[18] - Cash and cash equivalents at the end of the period were RMB 308.98 million, down from RMB 466.84 million at the beginning of the period[18] - Total cash inflows from operating activities were RMB 653.30 million, compared to RMB 636.44 million in the previous period[17] - Total cash outflows from operating activities were RMB 599.75 million, compared to RMB 565.73 million in the previous period[17] Research and Development - R&D expenses decreased by 30.56% to RMB 21.50 million due to reduced equity incentive payments[7] - Research and development expenses decreased to 21,497,467.73 RMB from 30,959,515.47 RMB[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 9,977[8] - The top shareholder, Chen Yanggui, holds 8.86% of the shares, amounting to 7,444,165 shares[9] - The company's 2024 employee stock ownership plan holds 2.32% of the shares, amounting to 1,947,030 shares[9] Earnings Per Share - The company's basic earnings per share increased by 17.29% to RMB 0.23[3] - Basic earnings per share were RMB 0.62, compared to RMB 0.49 in the previous period[16] - Diluted earnings per share were RMB 0.62, compared to RMB 0.49 in the previous period[16] Government Subsidies - Government subsidies received during the period amounted to RMB 865,561.85[4] Accounts Receivable - Accounts receivable increased by 85.21% to RMB 71.19 million due to delayed payments from major clients[6] - The company's accounts receivable increased to 71,186,203.85 yuan from 38,434,825.43 yuan at the beginning of the period[11] Long-term Equity Investments - The company's long-term equity investments increased by 142.09% to RMB 85.81 million due to new investments in affiliated companies[6] - The company's long-term equity investments increased to 85,812,883.33 yuan from 35,446,937.95 yuan at the beginning of the period[11] Miscellaneous - The company's third-quarter report was unaudited[19]